pioglitazone has been researched along with Barrett Epithelium in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the biological effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's adenocarcinoma cells in vitro and in vivo." | 3.75 | Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo. ( Al-Taie, OH; Barthelmes, HU; Graf, T; Illert, B; Katzenberger, T; Kraus, MR; Mörk, H; Scheurlen, M; Seufert, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Taie, OH | 1 |
| Graf, T | 1 |
| Illert, B | 1 |
| Katzenberger, T | 1 |
| Mörk, H | 1 |
| Kraus, MR | 1 |
| Barthelmes, HU | 1 |
| Scheurlen, M | 1 |
| Seufert, J | 1 |
1 other study available for pioglitazone and Barrett Epithelium
| Article | Year |
|---|---|
Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Apoptosis; Barrett Esophagus; Cell Line, Tumor; Cell Proliferation; Esophag | 2009 |